NEW YORK (GenomeWeb) – Nanosphere has closed its direct offering of $4.4 million Series A convertible preferred stock and has secured a $30 million debt facility with NSPH Funding, an affiliate of Life Sciences Alternative Funding and SWK Funding.
...and receive Daily News bulletins.
Already have an account?Login Now.
The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.
Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.
Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.
In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.